Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine product

“This is the 16th vaccine to enter trials globally but is the first COVID-19 vaccine developed in the Southern hemisphere to enter human trials, and the first COVID-19 vaccine designed with the help of AI,” said Professor Nikolai Petrovsky.

Sypharma has a long-standing relationship with Vaxine with over a decade of manufacturing Advax delta inulin adjuvant, and are excited and are honored to partner with this groundbreaking work in bringing a CoVID-19 vaccine to market. Sypharma undertook the fill and finish of the  CoVID-19 vaccine and the manufacture of the Advax delta inulin adjuvant products.

Link to the article